Phytol derivatives as drug resistance reversal agents

ChemMedChem

Volumn 9, Issue 8, 2014, Pages 1860-1868

  Upadhyay, Harish C ^a   Dwivedi, Gaurav R ^b   Roy, Sudeep ^b,c   Sharma, Ashok ^b   Darokar, Mahendra P ^b   Srivastava, Santosh K ^a  

^a Medicinal Chemistry Department   (India)

^b CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^c BRNO UNIVERSITY OF TECHNOLOGY   (Czech Republic)

Author keywords

antibiotics; docking studies; drug resistance; efflux pumps; phytol

Indexed keywords

1 BROMO 3,7,11,15 TETRAMETHYL 2 HEXADECENE; 1 O (2,3 DICHLOROBENZOYL)PHYTOL; 1 O (3 CHLOROPROPIONYL)PHYTOL; 1 O (3,4,5 TRIMETHOXYBENZOYL)PHYTOL; 1 O (M ANISOYL)PHYTOL; 1 O (TRANS CROTONYL)PHYTOL; 1 O ACETYLPHYTOL; 1 O BENZOYLPHYTOL; 1 O CINNAMOYLPHYTOL; 1 O LAUROYLPHYTOL; 1 O PALMITOYLPHYTOL; 1 O PIVALOYLPHYTOL; 3,7,11,15 TETRAMETHYL 2' PHENYLOCTADEC 1(1 ),2(3) DIENE 2' ONE; ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; ANTIBIOTIC AGENT; DIPHYTYLOXALATE; NALIDIXIC ACID; PHYTAL; PHYTOL; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BINDING AFFINITY; BLOOD BRAIN BARRIER; COMPUTER MODEL; CONCENTRATION RESPONSE; COST EFFECTIVENESS ANALYSIS; DOWN REGULATION; DRUG RESISTANCE; DRUG SCREENING; DRUG SYNTHESIS; EFFUSION; ESCHERICHIA COLI; INTESTINE ABSORPTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; ANTAGONISTS AND INHIBITORS; ANTIBIOTIC RESISTANCE; BINDING SITE; CHEMISTRY; DRUG EFFECTS; METABOLISM; MICROBIAL SENSITIVITY TEST; PROTEIN TERTIARY STRUCTURE;

ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DOCKING SIMULATION; PHYTOL; PROTEIN STRUCTURE, TERTIARY;

EID: 84905220891     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201402027     Document Type: Article

References (41)

1. K. E. Jones, N. G. Patel, M. A. Levy, A. Storeygard, D. Balk, J. L. Gittleman, P. Daszak, Nature 2008, 451, 990-993.
2. R. Gaynes, J. R. Edwards, National Nosocomial Infections Surveillance System, Clin. Infect. Dis. 2005, 42, 848-854.
3. R. A. Weinstein, Am. J. Med. 1991, 91, 179S-184S.
4. A. Y. Peleg, D. C. Hooper, N. Engl. J. Med. 2010, 362, 1804-1813.
5. J. Davies, Science 1994, 264, 375-382.
6. F. C. Tenover, Am. J. Med. 2006, 119, S 3 -S 10.
7. M. Muñoz-Ochoa, J. I. Murillo-Álvarez, L. A. Zermeño-Cervantes, S. Martínez-Diaz, R. Rodríguez-Riosmena, Eur. Rev. Med. Pharmacol. Sci. 2010, 14, 739-747.
8. H. Nikaido, J. Bacteriol. 1996, 178, 5853-5859.
9. M. Markowitz, B. Y. Nguyen, E. Gotuzzo, F. Mendo, W. Ratanasuwan, C. Kovacs, G. Prada, J. O. Morales-Ramirez, C. S. Crumpacker, R. D. Isaacs, L. R. Gilde, H. Wan, M. D. Miller, L. A. Wenning, H. Teppler, Protocol 004 Part II Study Team, J. Acquired Immune Defic. Syndr. 2007, 46, 125-133.
10. K. A. Marr, M. Boeckh, R. A. Carter, H. W. Kim, L. Corey, Clin. Infect. Dis. 2004, 39, 797-802.
11. P. B. Bloland, M. Ettling, S. Meek, Bull. World Health Organ. 2000, 78, 1378-1388.
12. M. Martins, S. G. Dastidar, S. Fanning, J. E. Kristiansen, J. Molnar, J.-M. Pages, Z. Schelz, G. Spengler, M. Viveiros, L. Amaral, Int. J. Antimicrob. Agents 2008, 31, 198-208.
13. Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment:, S. P. S. Khanuja, J. S. Arya, S. K. Srivastava, A. K. Shasany, T. R. Santhakumar, M. P. Darokar, S. Kumar, Int. PCT Pub. No. WO 2003080059 A1, US Pat. No. US 20030181425, Indian Pat. No. IN 233906, 2003.
14. S. P. S. Khanuja, J. S. Arya, R. S. K. Tiruppadiripulivur, D. Saikia, H. Kaur, M. Singh, S. C. Gupta, A. K. Shasany, M. P. Darokar, S. K. Srivastava, M. M. Gupta, S. C. Verma, A. Pal, Nitrile glycosides useful as a bio-enhancer of drugs and nutrients, process of its isolation from, Moringa oleifera. US Patent 6,858,588, 2005.
15. J. Jia, F. Zhu, X. Ma, Z. W. Cao, Y. X. Li, Y. Z. Chen, Nat. Rev. Drug Discovery 2009, 8, 111-128.
16. G. Cottarel, J. Wierzbowski, Trends Biotechnol. 2007, 25, 547-555.
17. D. D. Raga, R. A. Espiritu, C.-C. Shen, C. Y. Ragasa, J. Nat. Med. 2011, 65, 206-211.
18. C. Y. Ragasa, E. S. C. Javier, I. G. Tan, Philipp. J. Sci. 2003, 132, 21-25.
19. J. Gloerich, D. M. van den Brink, J. P. N. Ruiter, N. van Vlies, F. M. Vaz, R. J. A. Wanders, S. Ferdinandusse, J. Lipid Res. 2007, 48, 77-85.
20. M. S. Butler, A. D. Buss, Biochem. Pharmacol. 2006, 71, 919-929.
21. J. P. Saludes, M. J. Garson, S. G. Franzblau, A. M. Aguinaldo, Phytother. Res. 2002, 16, 683-685.
22. M. S. Rajab, C. L. Cantrell, S. G. Franzblau, N. H. Fischer, Planta Med. 1998, 64, 2-4.
23. D. Saikia, S. Parihar, D. Chanda, S. Ojha, J. K. Kumar, C. S. Chanotiya, K. Shanker, A. S. Negi, Bioorg. Med. Chem. Lett. 2010, 20, 508-512.
24. H. C. Upadhyay, G. R. Dwivedi, M. P. Darokar, V. Chaturvedi, S. K. Srivastava, Planta Med. 2012, 78, 79-81.
25. A. Maurya, G. R. Dwivedi, S. K. Srivastava, M. P. Darokar, Chem. Biol. Drug Des. 2013, 81, 484-490.
26. V. K. Gupta, S. Verma, A. Pal, S. K. Srivastava, P. K. Srivastava, M. P. Darokar, Appl. Microbiol. Biotechnol. 2013, 97, 9121-9131.
27. H. C. Upadhyay, J. P. Thakur, D. Saikia, S. K. Srivastava, Med. Chem. Res. 2013, 22, 16-21.
28. M. L. Go, X. Wu, X. L. Liu, Curr. Med. Chem. 2005, 12, 481-499.
29. B. A. Bhat, K. L. Dhar, S. C. Puri, A. K. Saxena, M. Shanmugavel, G. N. Qazi, Bioorg. Med. Chem. Lett. 2005, 15, 3177-3180.
30. T. Narender, K. P. Reddy, Tetrahedron Lett. 2007, 48, 3177-3180.
31. P. Cos, A. J. Vlietinck, D. V. Berghe, L. Maes, J. Ethnopharmacol. 2006, 106, 290-302.
32. S. J. Schrag, V. Perrot, B. R. Levin, Proc. R. Soc. London Ser. B 1997, 264, 1287-1291.
33. G. R. Dwivedi, H. C. Upadhyay, D. K. Yadav, V. Singh, S. K. Srivastava, F. Khan, N. S. Darmwal, M. P. Darokar, Chem. Biol. Drug Design 2014, 83, 842-892.
34. B. Marquez, Biochimie 2005, 87, 1137-1147.
35. M. Viveiros, M. Dupont, L. Rodrigues, I. Couto, A. Davin-Regli, M. Martins, J. M. Pages, L. Amaral, PLoS One 2007, 2, e 365.
36. M. Viveiros, A. Jesus, M. Brito, C. Leandro, M. Martins, D. Ordway, A. M. Molnar, J. Molnar, L. Amaral, Antimicrob. Agents Chemother. 2005, 49, 3578-3582.
37. Clinical Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing, 15th Informational Supplement M100-S15, CLSI 2012, Wayne, PA (USA).
38. G. M. Eliopoulos, C. B. Wennersten, Antimicrob. Agents Chemother. 2002, 46, 1319-1324.
39. S. K. Pillai, R. C. Moellering, Jr., G. M. Eliopoulos, Antimicrobial combinations, in Antibiotics in Laboratory Medicine, 4 th ed., (Ed.: V. Lorian,), Williams & Wilkins, Baltimore, 1996, pp. 330-336.
40. M. Viveiros, L. Rodrigues, M. Martins, I. Couto, G. Spengler, A. Martins, L. Amaral, Methods Mol. Biol. 2010, 642, 159-172.
41. Y. Suzuki, S. Ueno, R. Ohnuma, N. Koyama, Biochim. Biophys. Acta Gene Struct. Expression 2005, 1727, 162-168.